Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Vote In favor of Your Favored Treat - 2Experience Is standing by: History's Most noteworthy Travelers
- 3How to sound like an astronaut as you follow the first human moon mission in more than half a century
- 4Instructions to Improve Your Mental Exploration with Cutting edge Measurements
- 5New trailer for 'Bridgerton' Season 4 teases Benedict's love story: Watch it here
- 6 Modest and Strong Tire Brands
- French Senate debates social media ban for under-15s
- The Ascent of Rousing Pioneers Who Formed History
- Vote in favor of Your #1 BWM Vehicles
- Seven deaths possibly linked to malfunctioning glucose monitors
- The most effective method to Shake Hands Expertly: A Bit by bit Guide
- Israeli Chief of Staff declares new border with Gaza Strip
- Greece eyes migrant repatriation centres outside the EU
- ISS astronaut snaps stunning nighttime photo of Florida and Cuba | Space photo of the day for Dec. 29, 2025
